BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Prostate cancer AND ZNF331, Q9NQX6, 55422, ENSG00000130844, ZNF361, RITA, ZNF463
12 results:

  • 1. A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study.
    Bancroft EK; Page EC; Brook MN; Thomas S; Taylor N; Pope J; McHugh J; Jones AB; Karlsson Q; Merson S; Ong KR; Hoffman J; Huber C; Maehle L; Grindedal EM; Stormorken A; Evans DG; Rothwell J; Lalloo F; Brady AF; Bartlett M; Snape K; Hanson H; James P; McKinley J; Mascarenhas L; Syngal S; Ukaegbu C; Side L; Thomas T; Barwell J; Teixeira MR; Izatt L; Suri M; Macrae FA; Poplawski N; Chen-Shtoyerman R; Ahmed M; Musgrave H; Nicolai N; Greenhalgh L; Brewer C; Pachter N; Spigelman AD; Azzabi A; Helfand BT; Halliday D; Buys S; Ramon Y Cajal T; Donaldson A; Cooney KA; Harris M; McGrath J; Davidson R; Taylor A; Cooke P; Myhill K; Hogben M; Aaronson NK; Ardern-Jones A; Bangma CH; Castro E; Dearnaley D; Dias A; Dudderidge T; Eccles DM; Green K; Eyfjord J; Falconer A; Foster CS; Gronberg H; Hamdy FC; Johannsson O; Khoo V; Lilja H; Lindeman GJ; Lubinski J; Axcrona K; Mikropoulos C; Mitra AV; Moynihan C; Ni Raghallaigh H; Rennert G; Collier R; ; Offman J; Kote-Jarai Z; Eeles RA
    Lancet Oncol; 2021 Nov; 22(11):1618-1631. PubMed ID: 34678156
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Mdm2-P53 Interaction Inhibitor with Cisplatin Enhances Apoptosis in Colon and prostate cancer Cells In-Vitro.
    Gupta A; Behl T; Heer HR; Deshmukh R; Sharma PL
    Asian Pac J Cancer Prev; 2019 Nov; 20(11):3341-3351. PubMed ID: 31759358
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. 20-Year Comparative Survival and Mortality of cancer of the Stomach by Age, Sex, Race, Stage, Grade, Cohort Entry Time-Period, Disease Duration & Selected ICD-O-3 Oncologic Phenotypes:
    Milano AF
    J Insur Med; 2019; 48(1):5-23. PubMed ID: 31609640
    [No Abstract]    [Full Text] [Related]  

  • 4. Association of sociodemographic and clinical variables with time to start prostate cancer treatment.
    Sacramento RS; Simião LJ; Viana KCG; Andrade MAC; Amorim MHC; Zandonade E
    Cien Saude Colet; 2019 Sep; 24(9):3265-3274. PubMed ID: 31508747
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [Epidemiologic profile and prognostic factors in clinically localized prostate adenocarcinoma submitted to surgical treatment].
    Nassif AE; Tâmbara Filho R; Paula RX; Taguchi WS; Pozzobon HJ
    Rev Col Bras Cir; 2009 Aug; 36(4):327-31. PubMed ID: 20076923
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [Radiofrequency interstitial tumor ablation (rita) for the treatment of localised prostate cancer].
    Bonillo García MA; Gimeno Argente V; Jiménez Cruz JF
    Actas Urol Esp; 2007 Jun; 31(6):627-32. PubMed ID: 17896559
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Histopathological findings after radiofrequency (rita) treatment for prostate cancer.
    Patriarca C; Bergamaschi F; Gazzano G; Corrada P; Ordesi G; Zanitzer L; Di Pasquale M; Giunta P; Campo B
    Prostate Cancer Prostatic Dis; 2006; 9(3):266-9. PubMed ID: 16683010
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Pilot study of radiofrequency interstitial tumor ablation (rita) for the treatment of radio-recurrent prostate cancer.
    Shariat SF; Raptidis G; Masatoschi M; Bergamaschi F; Slawin KM
    Prostate; 2005 Nov; 65(3):260-7. PubMed ID: 16015591
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Current status of minimally invasive treatment options for localized prostate carcinoma.
    Beerlage HP; Thüroff S; Madersbacher S; Zlotta AR; Aus G; de Reijke TM; de la Rosette JJ
    Eur Urol; 2000 Jan; 37(1):2-13. PubMed ID: 10671777
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Transperineal radiofrequency interstitial tumor ablation (rita) of the prostate.
    Djavan B; Susani M; Shariat S; Zlotta AR; Silverman DE; Schulman CC; Marberger M
    Tech Urol; 1998 Jun; 4(2):103-9. PubMed ID: 9623628
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Percutaneous transperineal radiofrequency ablation of prostate tumour: safety, feasibility and pathological effects on human prostate cancer.
    Zlotta AR; Djavan B; Matos C; Noel JC; Peny MO; Silverman DE; Marberger M; Schulman CC
    Br J Urol; 1998 Feb; 81(2):265-75. PubMed ID: 9488071
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Transperineal radiofrequency interstitial tumor ablation of the prostate: correlation of magnetic resonance imaging with histopathologic examination.
    Djavan B; Zlotta AR; Susani M; Heinz G; Shariat S; Silverman DE; Schulman CC; Marberger M
    Urology; 1997 Dec; 50(6):986-92; discussion 992-3. PubMed ID: 9426739
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.